Patrick H Maxwell Selected Research

Patrick H Maxwell Research Topics

Disease

60	Hypoxia (Hypoxemia) 03/2022 - 01/2002
22	Neoplasms (Cancer) 01/2019 - 02/2002
9	Renal Cell Carcinoma (Grawitz Tumor) 01/2018 - 05/2002
8	Anemia 03/2010 - 07/2002
6	Ischemia 04/2012 - 07/2002
5	Polycythemia (Erythrocytosis) 04/2017 - 12/2002
5	IGA Glomerulonephritis (IGA Nephropathy) 02/2013 - 07/2004
4	Kidney Neoplasms (Kidney Cancer) 01/2021 - 04/2006
4	Inflammation (Inflammations) 09/2017 - 12/2008
4	Kidney Diseases (Kidney Disease) 01/2017 - 05/2009
3	Genomic Instability 05/2016 - 12/2011
3	Carcinoma (Carcinomatosis) 04/2016 - 04/2008
3	Reperfusion Injury 10/2014 - 01/2008
3	Glomerulonephritis 02/2013 - 09/2010
2	Cysts 11/2016 - 10/2011
2	Myocardial Infarction 10/2014 - 07/2006
2	Neoplasm Metastasis (Metastasis) 05/2013 - 12/2010
2	Acute Kidney Injury (Acute Renal Failure) 11/2011 - 04/2009
2	Carcinogenesis 10/2011 - 11/2010
2	Renal Insufficiency (Renal Failure) 09/2010 - 05/2009
1	COVID-19 03/2022
1	Fibrosis (Cirrhosis) 01/2019
1	MASS syndrome 01/2018
1	Hepatitis B 01/2017
1	Vitamin D Deficiency 01/2017
1	Tyrosinemias (Tyrosinemia) 01/2017
1	Hepatic Insufficiency 01/2017
1	Intracranial Aneurysm (Cerebral Aneurysm) 11/2016
1	Muscle Cramp (Cramp) 11/2016
1	Rickets (Rachitis) 01/2016
1	Cicatrix (Scar) 10/2014

Drug/Important Bio-Agent (IBA)

28	Oxygen (Dioxygen)IBA 01/2021 - 06/2002
22	Transcription Factors (Transcription Factor)IBA 01/2021 - 02/2002
18	Proteins (Proteins, Gene)FDA Link 01/2018 - 02/2002
11	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 01/2018 - 01/2004
11	Erythropoietin FDA Link 04/2017 - 07/2002
10	EnzymesIBA 10/2017 - 01/2004
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2018 - 02/2002
5	Messenger RNA (mRNA)IBA 03/2022 - 09/2004
4	DNA (Deoxyribonucleic Acid)IBA 05/2016 - 07/2009
4	UbiquitinIBA 06/2013 - 05/2002
4	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 04/2006 - 01/2002
3	Mixed Function Oxygenases (Monooxygenases)IBA 10/2017 - 01/2008
3	Protein Isoforms (Isoforms)IBA 04/2017 - 07/2005
3	Complement System Proteins (Complement)IBA 02/2013 - 01/2006
3	Retinaldehyde (Retinal)IBA 07/2012 - 06/2010
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2011 - 02/2002
3	Fumarate Hydratase (Fumarase)IBA 10/2011 - 11/2010
3	oxalylglycineIBA 07/2011 - 01/2008
3	HepcidinsIBA 03/2010 - 05/2009
3	IronIBA 03/2010 - 05/2009
2	RNA (Ribonucleic Acid)IBA 03/2022 - 07/2009
2	CollagenIBA 01/2019 - 10/2017
2	Ligases (Synthetase)IBA 01/2018 - 06/2002
2	Prolyl-Hydroxylase InhibitorsIBA 09/2017 - 12/2010
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 04/2016 - 06/2013
2	Arginine (L-Arginine)FDA Link 03/2016 - 12/2002
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2016 - 01/2006
2	Retroelements (Retrotransposon)IBA 10/2015 - 12/2011
2	Immunoglobulins (Immunoglobulin)IBA 02/2013 - 05/2010
2	AntioxidantsIBA 02/2012 - 10/2011
2	Lactic Acid (Lactate)FDA LinkGeneric 11/2011 - 11/2010
2	FumaratesIBA 10/2011 - 11/2010
2	MimosineIBA 12/2010 - 01/2008
2	Hypoxia-Inducible Factor 1IBA 12/2010 - 07/2005
2	Pharmaceutical PreparationsIBA 06/2010 - 05/2010
2	Hormones (Hormone)IBA 03/2010 - 02/2008
2	Carbon MonoxideIBA 11/2009 - 07/2002
2	Small Interfering RNA (siRNA)IBA 04/2009 - 08/2005
2	Cadherins (E-Cadherin)IBA 02/2009 - 04/2006
2	3' Untranslated Regions (3' UTR)IBA 06/2006 - 07/2004
1	Factor V (Coagulation Factor V)IBA 03/2022
1	ChromatinIBA 01/2021
1	Histone MethyltransferasesIBA 01/2021
1	endothelial PAS domain-containing protein 1IBA 01/2021
1	Complement C1q (C1q Complement)IBA 10/2017
1	fumarylacetoacetase (fumarylacetoacetate hydrolase)IBA 01/2017
1	sodium-bile acid cotransporterIBA 01/2017
1	fumarylacetoacetateIBA 01/2017
1	Bile Acids and Salts (Bile Acids)IBA 01/2017
1	Mitochondrial DNA (mtDNA)IBA 01/2017
1	LipidsIBA 01/2017
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2017
1	Tyrosine (L-Tyrosine)FDA Link 01/2017
1	Collagen Type IV (Type IV Collagen)IBA 11/2016
1	Creatine Kinase (Creatine Phosphokinase)IBA 11/2016
1	ADI PEG20IBA 03/2016
1	CalciumIBA 01/2016
1	Indicators and Reagents (Reagents)IBA 10/2014
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 10/2014
1	Mitochondrial Permeability Transition PoreIBA 10/2014
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 02/2014
1	Biomarkers (Surrogate Marker)IBA 10/2013
1	p38 Mitogen-Activated Protein KinasesIBA 06/2013
1	Deubiquitinating EnzymesIBA 06/2013

Therapy/Procedure

3	Therapeutics 03/2016 - 04/2009
2	Ligation 07/2006 - 09/2004
1	Homologous Transplantation 01/2017
1	Transplantation 04/2016
1	Molecular Targeted Therapy 10/2013